The new agreement enables GlaxoSmithKline (GSK) to provide enterprise-wide Ingenuity Pathways Analysis (IPA) access to researchers for rapid assessment of the signaling and metabolic pathways, molecular networks, and
While Regulatory authorities are concerned with assessing the safety, quality and efficacy of a product, the healthcare technology assessment (HTA) bodies monitor the product’s relative effectiveness and potential
According to the Commission, increased penetration of the classical supply chain by the counterfeiters has led to a sharp rise of counterfeit drugs and seized fake medicines at
The development candidate is an extended release formulation of low dose glucagon for the prevention of insulin-induced hypoglycemia in patients with diabetes. Terms of the agreement include an
The approvable letter indicates that the ceftobiprole application is approvable, subject to completion and assessment of clinical study site inspections, assessment of clinical and microbiological data provided but
In this Phase I/II clinical study, the treatment has so far been safe and tolerable. Samples taken before, during and after treatment showed that before vaccination the patient
The extension study was aimed to assess the tolerability and safety of Privigen, when administered at infusion rates higher than those of the pivotal study (12mg/kg/min, as opposed
The preliminary data to date has indicated that Triolex is safe and well tolerated at all doses studied. In addition, the preliminary data thus far suggest that Triolex
MLN3126 is a selective antagonist of CCR9, a chemokine receptor known to be important in the migration of inflammatory cells into the gastrointestinal tract. MLN3126 expands the company’s
The multi-year agreement stipulates that the distributor must meet a defined set of sales performance criteria. NIR Diagnostics is currently not disclosing the name of the distributor pending
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.